{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:01:55Z","timestamp":1791464515603,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.chest.2026.05.035","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T16:12:57Z","timestamp":1781021577000},"page":"1249-1259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recurrent VTE During Anticoagulation"],"prefix":"10.1016","volume":"170","author":[{"given":"Luc\u00eda","family":"Ordieres-Ortega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1321-6866","authenticated-orcid":false,"given":"Francisco","family":"Galeano-Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"L\u00f3pez-Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n","family":"Alonso-Beato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Demelo-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.chest.2026.05.035_bib1","first-page":"377","article-title":"Recurrent venous thromboembolism","volume":"105","author":"Mount","year":"2022","journal-title":"Am Fam Physician"},{"issue":"4","key":"10.1016\/j.chest.2026.05.035_bib2","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jtha.2025.01.009","article-title":"Basics of diagnosis and treatment of venous thromboembolism","volume":"23","author":"Cox","year":"2025","journal-title":"J Thromb Haemost"},{"issue":"25","key":"10.1016\/j.chest.2026.05.035_bib3","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1182\/blood-2017-03-742304","article-title":"How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapy","volume":"129","author":"Schulman","year":"2017","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.chest.2026.05.035_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.chest.2026.05.035_bib5","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/rth2.12218","article-title":"Asymptomatic \u201cbreakthrough\u201d thrombosis and anticoagulant \u201cfailure\u201d: keep calm and carry on","volume":"3","author":"Olson","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"issue":"11","key":"10.1016\/j.chest.2026.05.035_bib6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.31083\/j.rcm2511406","article-title":"Thromboembolism in patients with cancer: a practical guide to recurrent events","volume":"25","author":"Kozhukhov","year":"2024","journal-title":"Rev Cardiovasc Med"},{"issue":"18","key":"10.1016\/j.chest.2026.05.035_bib7","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1182\/blood-2011-05-357343","article-title":"Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study","volume":"118","author":"Heit","year":"2011","journal-title":"Blood"},{"issue":"02","key":"10.1016\/j.chest.2026.05.035_bib8","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1055\/a-2173-7729","article-title":"Recurrent venous thromboembolism in patients on anticoagulation: an update based on the revised AWMF S2k guideline","volume":"44","author":"Klamroth","year":"2024","journal-title":"Hamostaseologie"},{"issue":"1","key":"10.1016\/j.chest.2026.05.035_bib9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.acvd.2023.11.006","article-title":"Recurrent venous thromboembolism in anticoagulated cancer patients: diagnosis and treatment","volume":"117","author":"Bertoletti","year":"2024","journal-title":"Arch Cardiovasc Dis"},{"issue":"10480","key":"10.1016\/j.chest.2026.05.035_bib10","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0140-6736(24)02842-3","article-title":"Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial","volume":"405","author":"Couturaud","year":"2025","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.chest.2026.05.035_bib11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/ATVBAHA.108.182428","article-title":"Venous thromboembolism","volume":"29","author":"Zhu","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"22","key":"10.1016\/j.chest.2026.05.035_bib12","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1001\/archinte.160.22.3431","article-title":"Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy","volume":"160","author":"Douketis","year":"2000","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.chest.2026.05.035_bib13","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1538-7836.2009.03326.x","article-title":"Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients","volume":"7","author":"Carrier","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"12","key":"10.1016\/j.chest.2026.05.035_bib14","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1016\/j.jtha.2025.08.022","article-title":"Management of recurrent venous thromboembolism during anticoagulant treatment in patients with cancer: a prospective cohort study","volume":"23","author":"Lanting","year":"2025","journal-title":"J Thromb Haemost"},{"issue":"20","key":"10.1016\/j.chest.2026.05.035_bib15","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1200\/JCO.2018.78.8034","article-title":"Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D)","volume":"36","author":"Young","year":"2018","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.chest.2026.05.035_bib16","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1056\/NEJMoa1711948","article-title":"Edoxaban for the treatment of cancer-associated venous thromboembolism","volume":"378","author":"Raskob","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.chest.2026.05.035_bib17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/jth.14662","article-title":"Apixaban and dalteparin in active malignancy-associated venous thromboembolism: the ADAM VTE trial","volume":"18","author":"McBane","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"11","key":"10.1016\/j.chest.2026.05.035_bib18","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1016\/j.jtha.2024.08.006","article-title":"The use of direct oral anticoagulants in the secondary prevention of venous thromboembolism in patients with severe thrombophilia: communication from the ISTH SSC Subcommittee on Physiological Anticoagulants and Thrombophilia","volume":"22","author":"Kovac","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"19","key":"10.1016\/j.chest.2026.05.035_bib19","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1182\/blood.2024027879","article-title":"Molecular determinants of thrombosis recurrence risk across venous thromboembolism subtypes","volume":"146","author":"Munsch","year":"2025","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.chest.2026.05.035_bib20","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.chest.2026.05.035_bib21","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/j.jtha.2025.02.022","article-title":"Treatment and outcomes after on-treatment recurrent venous thromboembolism in patients with cancer: a post hoc analysis of the Hokusai venous thromboembolism cancer study","volume":"23","author":"Lanting","year":"2025","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.chest.2026.05.035_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-26947-9","article-title":"Clinical characteristics, management strategies and outcomes of patients with recurrent venous thromboembolism in the real world","volume":"12","author":"Yamashita","year":"2022","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.chest.2026.05.035_bib23","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1183\/09031936.00087608","article-title":"Risk factors for chronic thromboembolic pulmonary hypertension","volume":"33","author":"Bonderman","year":"2009","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2026.05.035_bib24","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/asheducation-2016.1.413","article-title":"The post-thrombotic syndrome","volume":"2016","author":"Kahn","year":"2016","journal-title":"Hematology"},{"issue":"03","key":"10.1016\/j.chest.2026.05.035_bib25","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1055\/a-1171-0486","article-title":"How to differentiate recurrent deep vein thrombosis from postthrombotic syndrome","volume":"40","author":"Gautam","year":"2020","journal-title":"Hamostaseologie"},{"issue":"10","key":"10.1016\/j.chest.2026.05.035_bib26","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1016\/j.jtha.2025.06.019","article-title":"Performance of clinical decision rules in patients presenting with suspected recurrent venous thromboembolism: a multicenter prospective cohort study","volume":"23","author":"Mai","year":"2025","journal-title":"J Thromb Haemost"},{"issue":"12","key":"10.1016\/j.chest.2026.05.035_bib27","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1111\/j.1538-7836.2011.04533.x","article-title":"Baseline imaging after therapy for unprovoked venous thromboembolism: a randomized controlled comparison of baseline imaging for diagnosis of suspected recurrence","volume":"9","author":"Hamadah","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1016\/j.chest.2026.05.035_bib28","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/jmri.22379","article-title":"Magnetic resonance imaging and computed tomography developments in imaging of venous thromboembolism","volume":"32","author":"van Langevelde","year":"2010","journal-title":"J Magn Reson Imaging"},{"issue":"16","key":"10.1016\/j.chest.2026.05.035_bib29","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1182\/blood.2019004114","article-title":"Magnetic resonance imaging for diagnosis of recurrent ipsilateral deep vein thrombosis","volume":"135","author":"van Dam","year":"2020","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.chest.2026.05.035_bib30","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1177\/1358863X231198069","article-title":"Noninvasive and invasive imaging of lower-extremity acute and chronic venous thrombotic disease","volume":"28","author":"Li","year":"2023","journal-title":"Vasc Med"},{"issue":"1","key":"10.1016\/j.chest.2026.05.035_bib31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2020.09.023","article-title":"Editor\u2019s choice\u2014European Society for Vascular Surgery (ESVS) 2021 clinical practice guidelines on the management of venous thrombosis","volume":"61","author":"Kakkos","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"07","key":"10.1016\/j.chest.2026.05.035_bib32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1160\/TH14-10-0842","article-title":"Thromboembolic resolution assessed by CT pulmonary angiography after treatment for acute pulmonary embolism","volume":"114","author":"den Exter","year":"2015","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.chest.2026.05.035_bib33","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jtha.2025.10.031","article-title":"Optimal adherence thresholds for oral anticoagulants in patients with atrial fibrillation using machine learning and population administrative data","volume":"24","author":"Safari","year":"2026","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.chest.2026.05.035_bib34","article-title":"Self-reported treatment burden: a comparison between vitamin K and non-vitamin K oral anticoagulants","volume":"19","author":"Mihajlovic","year":"2025","journal-title":"Explor Res Clin Soc Pharm"},{"issue":"6","key":"10.1016\/j.chest.2026.05.035_bib35","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.semerg.2015.08.004","article-title":"Grado de control y cumplimiento terap\u00e9utico de la anticoagulaci\u00f3n con acenocumarol en atenci\u00f3n primaria [Level of control and treatment adherence of anticoagulation with acenocoumarol in primary care]","volume":"42","author":"Precioso Costa","year":"2016","journal-title":"Semergen"},{"key":"10.1016\/j.chest.2026.05.035_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.994085","article-title":"Adherence and persistence to oral anticoagulants in patients with atrial fibrillation: a Belgian nationwide cohort study","volume":"9","author":"Grymonprez","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.chest.2026.05.035_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2025-003536","article-title":"Overview of direct oral anticoagulation trends in the Bronx: case control study of patient and systemic factors in medication non-adherence","volume":"13","author":"Khasnavis","year":"2026","journal-title":"Open Heart"},{"issue":"7","key":"10.1016\/j.chest.2026.05.035_bib38","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s40261-022-01165-3","article-title":"Thromboembolic events while taking direct oral anticoagulants: an analysis of post-market WHO database reports from 2012 to 2020","volume":"42","author":"Mitrovic","year":"2022","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.chest.2026.05.035_bib39","series-title":"Eliquis (Apixaban): EPAR\u2014Product Information","year":"2024"},{"issue":"8","key":"10.1016\/j.chest.2026.05.035_bib41","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/jth.15358","article-title":"Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation","volume":"19","author":"Martin","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1016\/j.chest.2026.05.035_bib42","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.medcli.2024.10.020","article-title":"Direct oral anticoagulants versus vitamin K antagonists in patients with thrombotic antiphospholipid syndrome: a prospective observational analysis","volume":"164","author":"Demelo-Rodr\u00edguez","year":"2025","journal-title":"Med Clin (Barc)"},{"issue":"19","key":"10.1016\/j.chest.2026.05.035_bib43","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"issue":"12","key":"10.1016\/j.chest.2026.05.035_bib44","first-page":"e977","article-title":"2026 AHA\/ACC\/ACCP\/ACEP\/CHEST\/SCAI\/SHM\/SIR\/SVM\/SVN guideline for the evaluation and management of acute pulmonary embolism in adults: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"153","author":"Creager","year":"2026","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.chest.2026.05.035_bib45","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1200\/JCO.2013.49.1118","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update","volume":"31","author":"Lyman","year":"2013","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.chest.2026.05.035_bib46","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1016\/j.jtha.2025.06.025","article-title":"A systematic review on anti-Xa monitoring in the therapeutic use of low-molecular-weight heparins","volume":"23","author":"Jaspers","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.chest.2026.05.035_bib47","first-page":"19","article-title":"Factors XI and XII as targets for new anticoagulants","volume":"4","author":"Weitz","year":"2017","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"10.1016\/j.chest.2026.05.035_bib48","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.3324\/haematol.2023.283682","article-title":"Novel horizons in anticoagulation: the emerging role of factor XI inhibitors across different settings","volume":"109","author":"Cohen","year":"2024","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.chest.2026.05.035_bib49","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1016\/j.chest.2021.07.055","article-title":"Antithrombotic therapy for VTE disease","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.chest.2026.05.035_bib50","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.jvir.2020.06.014","article-title":"Society of Interventional Radiology clinical practice guideline for inferior vena cava filters in the treatment of patients with venous thromboembolic disease","volume":"31","author":"Kaufman","year":"2020","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.chest.2026.05.035_bib51","doi-asserted-by":"crossref","first-page":"vi85","DOI":"10.1093\/annonc\/mdr392","article-title":"Management of venous thromboembolism (VTE) in cancer patients: ESMO clinical practice guidelines","volume":"22","author":"Mandal\u00e0","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.chest.2026.05.035_bib52","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejim.2023.10.014","article-title":"Chronic inflammatory diseases increase the risk of post-thrombotic syndrome: a prospective cohort study","volume":"120","author":"Iding","year":"2024","journal-title":"Eur J Intern Med"},{"issue":"21","key":"10.1016\/j.chest.2026.05.035_bib53","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1182\/blood.2023022329","article-title":"Venous and arterial thrombosis in patients with VEXAS syndrome","volume":"143","author":"Kusne","year":"2024","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.chest.2026.05.035_bib54","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1182\/bloodadvances.2025017617","article-title":"Bleeding and thrombotic outcomes in patients with inflammatory bowel disease and venous thromboembolism","volume":"10","author":"Dawwas","year":"2026","journal-title":"Blood Adv"},{"key":"10.1016\/j.chest.2026.05.035_bib55","doi-asserted-by":"crossref","unstructured":"Chopard R, Piazza G, Bertoletti L, et al. RIETE Investigators. Clinical outcomes of venous thromboembolism in patients with ankylosing spondylitis vs. other immune-mediated inflammatory diseases: insights from the RIETE registry [published online ahead of print November 12, 2025]. Thromb Haemost. https:\/\/doi.org\/10.1055\/a-2722-7327","DOI":"10.1055\/a-2722-7327"},{"issue":"10","key":"10.1016\/j.chest.2026.05.035_bib56","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3390\/jcm10102061","article-title":"Venous thromboembolic disease in chronic inflammatory lung diseases: knowns and unknowns","volume":"10","author":"Keramidas","year":"2021","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.chest.2026.05.035_bib57","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s11739-019-02237-7","article-title":"Clinical features and management of venous thromboembolism in patients with Beh\u00e7et\u2019s syndrome: a single-center case-control study","volume":"15","author":"Toledo-Samaniego","year":"2020","journal-title":"Intern Emerg Med"},{"issue":"1","key":"10.1016\/j.chest.2026.05.035_bib58","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s11239-022-02637-1","article-title":"Arterial and venous involvement in Beh\u00e7et\u2019s syndrome: a narrative review","volume":"54","author":"Toledo-Samaniego","year":"2022","journal-title":"J Thromb Thrombolysis"},{"issue":"6","key":"10.1016\/j.chest.2026.05.035_bib59","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2174\/0115701611330090250130075810","article-title":"Comparative efficacy and safety of direct oral anticoagulants and warfarin in morbidly obese patients (BMI > 40 kg\/m2): a systematic review and meta-analysis","volume":"23","author":"Sagris","year":"2025","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.chest.2026.05.035_bib60","doi-asserted-by":"crossref","DOI":"10.1177\/10760296231153638","article-title":"Pharmacokinetics and dosing regimens of direct oral anticoagulants in morbidly obese patients: an updated literature review","volume":"29","author":"Zhao","year":"2023","journal-title":"Clin Appl Thromb Hemost"},{"issue":"01","key":"10.1016\/j.chest.2026.05.035_bib61","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1055\/s-0043-1776989","article-title":"Direct-acting oral anticoagulants in patients at extremes of body weight: a review of pharmacological considerations and clinical implications","volume":"08","author":"Talerico","year":"2024","journal-title":"TH Open"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369226007701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369226007701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:41:43Z","timestamp":1791463303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369226007701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0012369226007701"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2026.05.035","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrent VTE During Anticoagulation","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2026.05.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American College of Chest Physicians. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}